Székely, A.; Pállinger, É.; Töreki, E.; Ifju, M.; Barta, B.A.; Szécsi, B.; Losoncz, E.; Dohy, Z.; Barabás, I.J.; Kosztin, A.;
et al. Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation. Int. J. Mol. Sci. 2024, 25, 1752.
https://doi.org/10.3390/ijms25031752
AMA Style
Székely A, Pállinger É, Töreki E, Ifju M, Barta BA, Szécsi B, Losoncz E, Dohy Z, Barabás IJ, Kosztin A,
et al. Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation. International Journal of Molecular Sciences. 2024; 25(3):1752.
https://doi.org/10.3390/ijms25031752
Chicago/Turabian Style
Székely, Andrea, Éva Pállinger, Evelin Töreki, Mandula Ifju, Bálint András Barta, Balázs Szécsi, Eszter Losoncz, Zsófia Dohy, Imre János Barabás, Annamária Kosztin,
and et al. 2024. "Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation" International Journal of Molecular Sciences 25, no. 3: 1752.
https://doi.org/10.3390/ijms25031752
APA Style
Székely, A., Pállinger, É., Töreki, E., Ifju, M., Barta, B. A., Szécsi, B., Losoncz, E., Dohy, Z., Barabás, I. J., Kosztin, A., Buzas, E. I., Radovits, T., & Merkely, B.
(2024). Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation. International Journal of Molecular Sciences, 25(3), 1752.
https://doi.org/10.3390/ijms25031752
